Strata Skin Sciences Debt to Equity Ratio 2010-2025 | SSKN
Current and historical debt to equity ratio values for Strata Skin Sciences (SSKN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Strata Skin Sciences debt/equity for the three months ending March 31, 2025 was 5.71.
| Strata Skin Sciences Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2025-03-31 |
$0.03B |
$0.00B |
11.84 |
| 2024-12-31 |
$0.03B |
$0.01B |
6.27 |
| 2024-09-30 |
$0.03B |
$0.01B |
3.30 |
| 2024-06-30 |
$0.03B |
$0.01B |
3.17 |
| 2024-03-31 |
$0.03B |
$0.01B |
3.25 |
| 2023-12-31 |
$0.03B |
$0.01B |
2.31 |
| 2023-09-30 |
$0.03B |
$0.02B |
1.91 |
| 2023-06-30 |
$0.04B |
$0.02B |
2.27 |
| 2023-03-31 |
$0.03B |
$0.02B |
1.54 |
| 2022-12-31 |
$0.03B |
$0.02B |
1.39 |
| 2022-09-30 |
$0.03B |
$0.02B |
1.44 |
| 2022-06-30 |
$0.03B |
$0.02B |
1.40 |
| 2022-03-31 |
$0.03B |
$0.02B |
1.32 |
| 2021-12-31 |
$0.02B |
$0.03B |
0.83 |
| 2021-09-30 |
$0.02B |
$0.03B |
0.79 |
| 2021-06-30 |
$0.02B |
$0.03B |
0.74 |
| 2021-03-31 |
$0.02B |
$0.02B |
0.90 |
| 2020-12-31 |
$0.02B |
$0.03B |
0.81 |
| 2020-09-30 |
$0.02B |
$0.03B |
0.82 |
| 2020-06-30 |
$0.02B |
$0.03B |
0.73 |
| 2020-03-31 |
$0.02B |
$0.03B |
0.64 |
| 2019-12-31 |
$0.02B |
$0.03B |
0.65 |
| 2019-09-30 |
$0.02B |
$0.03B |
0.65 |
| 2019-06-30 |
$0.02B |
$0.03B |
0.63 |
| 2019-03-31 |
$0.02B |
$0.03B |
0.58 |
| 2018-12-31 |
$0.02B |
$0.03B |
0.52 |
| 2018-09-30 |
$0.01B |
$0.03B |
0.38 |
| 2018-06-30 |
$0.01B |
$0.03B |
0.37 |
| 2018-03-31 |
$0.02B |
$0.02B |
0.86 |
| 2017-12-31 |
$0.02B |
$0.02B |
0.97 |
| 2017-09-30 |
$0.02B |
$0.02B |
0.67 |
| 2017-06-30 |
$0.03B |
$0.01B |
2.69 |
| 2017-03-31 |
$0.03B |
$0.01B |
2.43 |
| 2016-12-31 |
$0.03B |
$0.02B |
1.94 |
| 2016-09-30 |
$0.03B |
$0.02B |
1.71 |
| 2016-06-30 |
$0.03B |
$0.02B |
1.57 |
| 2016-03-31 |
$0.03B |
$0.02B |
2.16 |
| 2015-12-31 |
$0.03B |
$0.02B |
2.11 |
| 2015-09-30 |
$0.04B |
$0.02B |
2.29 |
| 2015-06-30 |
$0.03B |
$0.03B |
1.00 |
| 2015-03-31 |
$0.01B |
$0.01B |
1.15 |
| 2014-12-31 |
$0.01B |
$0.01B |
0.64 |
| 2014-09-30 |
$0.01B |
$0.02B |
0.60 |
| 2014-06-30 |
$0.01B |
$0.01B |
0.75 |
| 2014-03-31 |
$0.01B |
$0.01B |
1.73 |
| 2013-12-31 |
$0.01B |
$0.01B |
0.70 |
| 2013-09-30 |
$0.00B |
$0.01B |
0.28 |
| 2013-06-30 |
$0.01B |
$0.02B |
0.52 |
| 2013-03-31 |
$0.01B |
$0.02B |
0.36 |
| 2012-12-31 |
$0.00B |
$0.01B |
0.24 |
| 2012-09-30 |
$0.00B |
$0.02B |
0.15 |
| 2012-06-30 |
$0.00B |
$0.02B |
0.13 |
| 2012-03-31 |
$0.00B |
$0.02B |
0.07 |
| 2011-12-31 |
$0.00B |
$0.03B |
0.05 |
| 2011-09-30 |
$0.00B |
$0.02B |
0.08 |
| 2011-06-30 |
$0.00B |
$0.02B |
0.06 |
| 2011-03-31 |
$0.00B |
$0.03B |
0.07 |
| 2010-12-31 |
$0.00B |
$0.03B |
0.06 |
| 2010-09-30 |
$0.00B |
$0.04B |
0.05 |
| 2010-06-30 |
$0.00B |
$0.03B |
0.07 |
| 2010-03-31 |
$0.00B |
$0.03B |
0.05 |
| 2009-12-31 |
$0.00B |
$0.03B |
0.06 |
| 2009-09-30 |
$0.00B |
$0.03B |
0.06 |
| 2009-06-30 |
$0.00B |
$0.01B |
0.18 |
| 2009-03-31 |
$0.00B |
$0.01B |
0.13 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$0.010B |
$0.034B |
|
Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania.
|
